← Back to Clinical Trials
Recruiting NCT06956417

NCT06956417 REhabilitation of MEMory Symptoms After BRain Concussion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06956417
Status Recruiting
Phase
Sponsor University of British Columbia
Condition Concussion, Brain
Study Type INTERVENTIONAL
Enrollment 184 participants
Start Date 2025-07-02
Primary Completion 2028-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Cognitive behavioral therapyCognitive rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 184 participants in total. It began in 2025-07-02 with a primary completion date of 2028-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Persistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both associated with improvements in subjective memory functioning. The present study will more definitively compare the effectiveness of these interventions for improving subjective memory functioning after concussion.

Eligibility Criteria

Inclusion Criteria: 1. Age 18-59 2. Concussion diagnosis confirmed with structured interview based on American Congress of Rehabilitation Medicine diagnostic criteria 3. Concussion occurred between 6 and 36 months before enrollment 4. Ongoing memory concerns 5. Fluent in English 6. Stable access to a computer, tablet, or smartphone with internet capability Exclusion Criteria: 1. Fail performance validity testing 2. Comorbid psychiatric or neurological disorder or is taking a medication that could fully account for their memory symptoms

Contact & Investigator

Central Contact

Noah D Silverberg, PhD

✉ noah.silverberg@ubc.ca

📞 6047341313

Principal Investigator

Noah D Silverberg, PhD

PRINCIPAL INVESTIGATOR

University of British Columbia

Frequently Asked Questions

Who can join the NCT06956417 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Concussion, Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06956417 currently recruiting?

Yes, NCT06956417 is actively recruiting participants. Contact the research team at noah.silverberg@ubc.ca for enrollment information.

Where is the NCT06956417 trial being conducted?

This trial is being conducted at Calgary, Canada, Langley, Canada, Vancouver, Canada, Hamilton, Canada and 4 additional locations.

Who is sponsoring the NCT06956417 clinical trial?

NCT06956417 is sponsored by University of British Columbia. The principal investigator is Noah D Silverberg, PhD at University of British Columbia. The trial plans to enroll 184 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology